We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Diagnostic Errors Lead to Inappropriate Antimicrobial Use

By LabMedica International staff writers
Posted on 01 Jun 2015
Misdiagnoses can lead to increased risk of incorrect antibiotic use, threatening patient outcomes and antimicrobial efficacy, while increasing healthcare costs.

All antimicrobial use establishes selective pressure that contributes to the relentless emergence of resistance in a broad array of pathogens and antimicrobial stewardship programs have been introduced to improve antimicrobial therapy, but in most cases improvements are modest.

Infectious disease specialists at the Minneapolis Veterans Affairs Health Care System, (Minnesota, MN, USA) and their university colleagues, conducted a retrospective cohort study at their Medical Center (MVAMC), evaluating 500 inpatient cases to examine provider diagnoses, categorized as either correct, indeterminate, incorrect, or a sign or symptom consistent with an infectious disease rather than a specific syndrome or disease, and to determine whether the antimicrobial course prescribed was appropriate. More...


The scientists found that 95% of patients with an incorrect or indeterminate diagnosis, or with a symptom identified but no diagnoses made, were given inappropriate antibiotics. By comparison, only 38% of patients who received a correct diagnosis were incorrectly given antibiotics. The inappropriate use of antibiotics contributes to antibiotic resistance, clinical failure, adverse drug events, and excessive costs. Additionally, they found that overall, only 58% of patients received a correct diagnosis, indicating that diagnostic errors were more prevalent in their study than in previous studies unrelated to antimicrobial use. The most common incorrect diagnoses identified by the specialists were pneumonia, cystitis, urinary tract infections, kidney infections and urosepsis.

The authors concluded that the impact of diagnostic accuracy on the appropriateness of antimicrobial therapy and they provide a detailed analysis of types and predictors of diagnostic errors and their relationship to types of inappropriate antimicrobial use. These findings suggest that more studies are needed to elucidate mechanisms of diagnostic errors related to antimicrobial prescribing. They also suggest that antimicrobial stewardship programs could increase their impact if they were designed to help providers make accurate initial diagnoses and to help providers know when antimicrobial therapy can be safely withheld.

Gregory A. Filice, MD, lead author of the study, said, “Diagnostic accuracy is integral to the safe use of antibiotics. In order to improve the use of antibiotics in healthcare, we must consider this challenge and look for tools and strategies that help clinicians decrease unnecessary and potentially harmful antibiotic use.” The study was published on May 18, 2015, in the journal Infection Control & Hospital Epidemiology

Related Links:
.
Minneapolis Veterans Affairs Health Care System 



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.